Clinical Trial Update: Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral doses of ZE63-0302 in adults with Type 2 D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ZE63-0302

Snippet

Sponsor: Eilean Therapeutics | Conditions: Type 2 Diabetes | Phase 1 | Status: RECRUITING